1. Home
  2. BLTE vs PHIN Comparison

BLTE vs PHIN Comparison

Compare BLTE & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • PHIN
  • Stock Information
  • Founded
  • BLTE 2018
  • PHIN 2023
  • Country
  • BLTE United States
  • PHIN United States
  • Employees
  • BLTE N/A
  • PHIN N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • PHIN
  • Sector
  • BLTE Health Care
  • PHIN
  • Exchange
  • BLTE Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • BLTE 2.1B
  • PHIN 1.8B
  • IPO Year
  • BLTE 2022
  • PHIN N/A
  • Fundamental
  • Price
  • BLTE $58.91
  • PHIN $51.02
  • Analyst Decision
  • BLTE Strong Buy
  • PHIN Buy
  • Analyst Count
  • BLTE 4
  • PHIN 2
  • Target Price
  • BLTE $96.33
  • PHIN $53.50
  • AVG Volume (30 Days)
  • BLTE 46.8K
  • PHIN 532.3K
  • Earning Date
  • BLTE 03-10-2025
  • PHIN 02-13-2025
  • Dividend Yield
  • BLTE N/A
  • PHIN 1.96%
  • EPS Growth
  • BLTE N/A
  • PHIN N/A
  • EPS
  • BLTE N/A
  • PHIN 2.34
  • Revenue
  • BLTE N/A
  • PHIN $3,452,000,000.00
  • Revenue This Year
  • BLTE N/A
  • PHIN N/A
  • Revenue Next Year
  • BLTE N/A
  • PHIN $1.04
  • P/E Ratio
  • BLTE N/A
  • PHIN $21.75
  • Revenue Growth
  • BLTE N/A
  • PHIN N/A
  • 52 Week Low
  • BLTE $31.01
  • PHIN $29.11
  • 52 Week High
  • BLTE $86.53
  • PHIN $57.23
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 46.75
  • PHIN 55.89
  • Support Level
  • BLTE $52.03
  • PHIN $50.30
  • Resistance Level
  • BLTE $61.66
  • PHIN $52.44
  • Average True Range (ATR)
  • BLTE 3.51
  • PHIN 1.31
  • MACD
  • BLTE 0.25
  • PHIN 0.49
  • Stochastic Oscillator
  • BLTE 42.55
  • PHIN 76.13

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About PHIN PHINIA Inc.

Phinia Inc is a leader in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications, and light vehicles. It is a global supplier to most major original equipment manufacturers (OEMs) and offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket. Phinia has an extensive original equipment portfolio of advanced fuel injection systems, fuel delivery modules, canisters, starters, alternators, sensors, electronic control modules, and associated software.

Share on Social Networks: